Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

Over the past decade, however, a wave of technological advances has begun to expand the druggable proteome. These include covalent inhibitors (such as sotorasib), chemical proteomics, and AI-enabled ...

About 4 billion people are now at risk of contracting dengue fever Small molecule treatments targeting virus replication mechanisms could be an effective answer Treatment options currently only ...

“The two big problems facing the pharmaceutical industry are price controls and an exaggerated incentive to abandon small molecule drugs in favor of biologics.” Over the last several years the ...

MITOLINE ™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases – A Market Projected to Exceed $120 billion by 2030 ...